Enhanced dissolution and spectroscopic analysis studies of the inclusion compound of Nevirapine in β-Cyclodextrin

International Journal of PharmTech Research

Volumn 3, Issue 1, 2011, Pages 144-147

  Sharma, Mukesh Chandra ^a   Sharma, Smita ^b  

^a DEVI AHILYA UNIVERSITY   (India)

^b Chodhary Dilip Singh Kanya Mahavidyalya   (India)

Author keywords

cyclodextrins; Inclusion complex; IR; Nevirapine

Indexed keywords

BETA CYCLODEXTRIN; NEVIRAPINE;

ARTICLE; DRUG MIXTURE; DRUG SOLUBILITY; FREEZE DRYING; INFRARED SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; ULTRAVIOLET SPECTROSCOPY;

EID: 79951573886     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Indian Pharmacopoeia 1996: Addendum 2002. New Delhi: The controller of Publications; 2002. p. 919-21.
2. Bekers O, Uijtendaal EV, Beijnen JH, Butt A, Underberg WJM., Drug Dev. Ind. Pharm,17 (11) 1503-1549,(1991).
3. Ammar HO, El-Nahhas SA, Emara LH., Pharmazie, 52 (5), 376-379,(1997).
4. Chowdary KP, Buchi NN., Drug Dev. Ind. Pharm,26 (11), 1217-1220,(2000).
5. Dhanraju MD, Kumaran K, Baskaran T, Moorty MS., Drug Dev. Ind. Pharm, 24 (6), 583-587,(1998).
6. Hedges AR, Shieh WJ, Sikorski CT., ACS Symposium series No, 590, 60,(1995).
7. Loftsson T, Brewster ME., J. Pharm. Sci, 85(10), 1017-1025,(1996).
8. Bruck SD. Controlled Drug Delivery, Vol.1, CRC Press, Boca Raton, USA, 125-148, (1983).
9. Atwood JL, Davis JED, MacNicol DD., Inclusion Compounds, Vol III. Academic Press, London, 333- 375(1983).
10. Linares MS, De Bertorello MM, Longhi MR., Drug Dev. Ind. Pharm, 26(9), 1003-1006, (2000).
11. Moyano JR, Arias-Blanco MJ, Gines JM, Rabasco AM, Perez-Martinez JI., Drug Dev. Ind. Pharm, 23 (4), 379-385,(1997).
12. Duchene D, Paris: Editions de Santè. 1992;351-407.
13. Frömming KH, Szejtli J. Kluwer Academic Publishers 1994.
14. Thompson DO. Crit Rev Ther Drug Carrier Syst.1997;14:1-104.
15. Masson M, Loftsson T, Masson G, Stefànsson ES. J Control Release, 59:107-118, 1999.